BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5261071)

  • 1. Remission induction with cytosine arabinoside and L-asparaginase in acute lymphoblastic leukaemia.
    McElwain TJ; Hardisty RM
    Br Med J; 1969 Dec; 4(5683):596-8. PubMed ID: 5261071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of acute lymphoblastic leukaemia (ALL) in childhood, UKALL III: the effects of added cytosine arabinoside and/or asparaginase, and a comparison of continuous or discontinuous mercaptopurine in regimens for standard risk ALL.
    Med Pediatr Oncol; 1982; 10(5):501-10. PubMed ID: 6755207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia.
    Steuber CP; Levy GJ; Nix WL; Shepherd DA; Starling KA; Fernbach DJ
    Med Pediatr Oncol; 1978; 5(1):33-8. PubMed ID: 311413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short courses of cytosine arabinoside and L-asparaginase in children with acute leukemia.
    Ekert H; Colebatch JH; Matthews RN
    Cancer; 1972 Sep; 30(3):643-7. PubMed ID: 4507080
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (ALL).
    Chessells JM; Cornbleet M
    Med Pediatr Oncol; 1979; 6(4):359-65. PubMed ID: 289904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of asparaginase in conjunction with cytosine arabinoside in acute leukemia in children.
    Hardisty RM; McElwain TJ
    Recent Results Cancer Res; 1970; 33():323-8. PubMed ID: 5292722
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential high-dose cytosine arabinoside and L-asparaginase in childhood leukemia in relapse.
    Ettinger LJ; Biener R; Finklestein JZ; Kamalakar P; Jones GR; Avramis VI; Holcenberg JS
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):155-9. PubMed ID: 3859930
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
    Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
    Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM
    Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847
    [No Abstract]   [Full Text] [Related]  

  • 10. L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone.
    Smithson WA; Gilchrist GS; Burgert EO
    Med Pediatr Oncol; 1979; 6(2):163-70. PubMed ID: 287856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.
    Crowther D; Bateman CJ; Vartan CP; Whitehouse JM; Malpas JS; Fairley GH; Scott RB
    Br Med J; 1970 Nov; 4(5734):513-7. PubMed ID: 4921703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective combination treatment of advanced acute lymphocytic leukemia with cytosine arabinoside (NSC-63878) and L-asparaginase (NSC-109229).
    Ortega JA; Finklestein JZ; Ertel I; Hammond D; Karon M
    Cancer Chemother Rep; 1972 Jun; 56(3):363-8. PubMed ID: 19051496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
    Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
    Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complete remission obtained in refractory acute lymphocytic leukemia using high-dose cytosine arabinoside combined with low-dose L-asparaginase].
    Inagaki C; Ito K; Omori I; Shimazaki C; Nishio A; Haruyama H; Isemura T; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):379-82. PubMed ID: 3855616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy for children with acute lymphocytic leukemia who fail to respond to standard remission-induction therapy.
    Lay HN; Ekert H; Colebatch JH
    Cancer; 1975 Oct; 36(4):1220-2. PubMed ID: 1058044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
    Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK
    J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Attempt of treatment of acute lymphoblastic leukemia by L-asparaginase].
    Mathé G; Amiel JL; Schwarzenberg L; Schneider M; Cattan A; Schlumberger JR; Hayat M; De Vassal F; Jasmin C; Rosenfeld C
    Presse Med (1893); 1969 Mar; 77(13):461-3. PubMed ID: 5255425
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential high-dose cytosine arabinoside-asparaginase treatment in advanced childhood leukemia.
    Wells RJ; Feusner J; Devney R; Woods WG; Provisor AJ; Cairo MS; Odom LF; Nachman J; Jones GR; Ettinger LJ
    J Clin Oncol; 1985 Jul; 3(7):998-1004. PubMed ID: 3860629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia.
    Pratt CB; Roberts D; Shanks E; Warmath EL; Jackson R
    Cancer Res; 1973 Sep; 33(9):2020-5. PubMed ID: 4516498
    [No Abstract]   [Full Text] [Related]  

  • 20. Favorable remission induction rate with twice weekly doses of L-asparaginase.
    Jaffe N; Traggis D; Das L; Frauenberger G; Hann HW; Kim BS; Bishop Y
    Cancer Res; 1973 Jan; 33(1):1-4. PubMed ID: 4565907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.